Back to search

Article

Genetically Adjusted PSA Levels for Prostate Cancer Screening

2022-04-21

Abstract excerpt

<h4>ABSTRACT</h4> Prostate-specific antigen (PSA) screening for prostate cancer remains controversial because it increases overdiagnosis and overtreatment of clinically insignificant tumors. Accounting for genetic determinants of constitutive, non-cancer-related PSA variation has potential to improve screening utility. We discovered 128 genome-wide significant associations ( P <5×10 -8 ) in a multi-ancestry meta-a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dfc14aa5-10ac-51d1-9ad5-3f7b2c2413b8
DOI
10.1101/2022.04.18.22273850
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetically Adjusted PSA Levels for Prostate Cancer ScreeningDOI 10.1101/2022.04.18.22273850
Select a neighboring publication to make it the new centre.